Calpain and pathology in view of structure-function relationships

Folia Pharmacologica Japonica

Volumn 122, Issue 1, 2003, Pages 21-29

  Sorimachi, Hiroyuki ^a   Kawabata, Yukiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

3D structure; Autolysis; Calpain; Muscular dystrophy; Proteolysis

Indexed keywords

CALCIUM ION; CALPAIN; CALPAIN 10; CALPAIN 3A; CALPAIN 3B; CYSTEINE PROTEINASE; PROTEIN; PROTEIN LP82; PROTEIN P94; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; AUTOLYSIS; CAPN10 GENE; CAPN3 GENE; CATARACT; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME STRUCTURE; GENE; GENE MUTATION; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MUSCULAR DYSTROPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PROTEIN DEGRADATION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURE ACTIVITY RELATION;

ANIMALS; CALPAIN; HUMANS; ISOENZYMES; MUSCULAR DYSTROPHIES; PROTEIN CONFORMATION;

EID: 0038268762     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.122.21     Document Type: Review

References (22)

1. Sorimachi H, Suzuki K. The structure of calpain. J Biochem. 2001;129:653-664.
2. Huang Y, Wang KK. The calpain family and human disease. Trends Mol Med. 2001;7:355-362.
3. Richard I, Broux O, Allamand V, et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell. 1995;81:27-40.
4. Horikawa Y, Oda N, Cox NJ, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet. 2000;26:163-175.
5. Sorimachi H, Toyama-Sorimachi N, Saido TC, et al. Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle. J Biol Chem. 1993;268:10593-10605.
6. Sorimachi H, Kinbara K, Kimura S, et al. Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence. J Biol Chem. 1995;270:31158-31162.
7. Kinbara K, Sorimachi H, Ishiura S, Suzuki K. Muscle-specific calpain, p94, interacts with the extreme C-terminal region of connectin, a unique region flanked by two immunoglobulin C2 motifs. Arch Biochem Biophys. 1997;342:99-107.
8. Ono Y, Shimada H, Sorimachi H, et al. Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A. J Biol Chem. 1998;273:17073-17078.
9. 2+-dependent protease activity and a novel mode of enzyme activation. EMBO J. 1999;18:6880-6889.
10. Strobl S, Fernandez-Catalan C, Braun M, et al. The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium. Proc Natl Acad Sci USA. 2000;97:588-592.
11. 2+-regulated phospholipid-binding domain. Biochem Biophys Res Commun. 2001;280:1333-1339.
12. 2+-dependent cysteine protease. FEBS Lett. 2001;501:111-114.
13. Nakagawa K, Masumoto H, Sorimachi H, Suzuki K. Dissociation of m-calpain subunits occurs after autolysis of the N-terminus of the catalytic subunit, and is not required for activation. J Biochem. 2001;130:605-611.
14. 2+ switch aligns the active site of calpain. Cell. 2002;108:649-660.
15. Ma H, Fukiage C, Azuma M, Shearer TR. Cloning and expression of mRNA for calpain Lp82 from rat lens: splice variant of p94. Invest Ophthalmol Vis Sci. 1998;39:454-461.
16. Fukiage C, Nakajima E, Ma H, Azuma M, Shearer TR. Characterization and regulation of lens-specific calpain Lp82. J Biol Chem. 2002;277:20678-20685.
17. Herasse M, Ono Y, Fougerousse F, et al. Expression and functional characteristics of calpain 3 isoforms generated through tissue-specific transcriptional and posttranscriptional events. Mol Cell Biol. 1999;19:4047-4055.
18. Spencer MJ, Guyon JR, Sorimachi H, et al. Stable expression of calpain 3 from a muscle transgene in vivo: immature muscle in transgenic mice suggests a role for calpain 3 in muscle maturation. Proc Natl Acad Sci U S A. 2002;99:8874-8879.
19. 2+-dependent intramolecular autolysis. FEBS Lett. 2002;532:401-406.
20. Richard I, Roudaut C, Saenz A, et al. Calpainopathy-a survey of mutations and polymorphisms. Am J Hum Genet. 1999;64:1524-1540.
21. Kawai H, Akaike M, Kunishige M, et al. Clinical, pathological, and genetic features of limb-girdle muscular dystrophy type 2A with new calpain 3 gene mutations in seven patients from three Japanese families. Muscle Nerve. 1998;21:1493-1501.
22. Humphrey W, Dalke A, Schulten K. VMD - visual molecular dynamics. J Mol Graph. 1996;14 (1):33-38.